| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Oct 9, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.98% | ✓ | $576K |
| Sep 11, 2025 | Sep 12, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -553 | -0.33% | ✗ | $23.8K |
| Sep 8, 2025 | Sep 10, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.96% | ✓ | $552.1K |
| Aug 5, 2025 | Aug 7, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.96% | ✓ | $616.3K |
| Jul 7, 2025 | Jul 9, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.96% | ✓ | $638.7K |
| Jun 18, 2025 | Jun 20, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -1,129 | -0.67% | ✗ | $61.9K |
| Jun 10, 2025 | Jun 12, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 42.5 | -2,358 | -1.39% | ✗ | $127.3K |
| Jun 5, 2025 | Jun 9, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 27.5 | -37,500 | -6.82% | ✓ | $2M |
| May 6, 2025 | May 8, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.86% | ✓ | $542.9K |
| Apr 24, 2025 | Apr 28, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 35.0 | -6,250 | -3.55% | ✓ | $256.4K |
| Apr 7, 2025 | Apr 10, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 37.5 | -6,250 | -3.55% | ✓ | $224.3K |
| Mar 12, 2025 | Mar 14, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -516 | -0.30% | ✗ | $23.2K |
| Mar 5, 2025 | Mar 7, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -12,500 | -6.84% | ✓ | $556.6K |
| Feb 5, 2025 | Feb 7, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 23.8 | -18,750 | -9.92% | ✓ | $1.1M |
| Jan 27, 2025 | Jan 29, 2025 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 15.0 | -31,250 | -15.51% | ✓ | $1.7M |
| Dec 17, 2024 | Dec 18, 2024 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 87.5 | +16,200 | 4.49% | ✓ | $118.2K |
| Dec 10, 2024 | Dec 12, 2024 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -4,818 | -1.33% | ✓ | $148.9K |
| Sep 10, 2024 | Sep 13, 2024 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -537 | -0.30% | ✗ | $14.1K |
| Jun 11, 2024 | Jun 13, 2024 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 42.5 | -2,380 | -1.30% | ✗ | $53.9K |
| Mar 13, 2024 | Mar 15, 2024 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -619 | -0.34% | ✗ | $17.5K |
| Dec 14, 2023 | Dec 18, 2023 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -514 | -0.28% | ✗ | $10.7K |
| Sep 13, 2023 | Sep 25, 2023 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 52.5 | -531 | -0.35% | ✓ | $26.7K |
| Jun 16, 2023 | Jun 21, 2023 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 17.5 | -78,200 | -34.09% | ✗ | $4.3M |
| Jun 13, 2023 | Jun 15, 2023 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 52.5 | -509 | -0.27% | ✓ | $28.1K |
| Mar 10, 2023 | Mar 14, 2023 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -603 | -0.32% | ✗ | $26.2K |
| Dec 28, 2022 | Dec 30, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 32.5 | -22,016 | -3.56% | ✓ | $1.1M |
| Nov 15, 2022 | Nov 16, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 35.0 | -7,085 | -3.71% | ✓ | $320.8K |
| Oct 25, 2022 | Oct 27, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -15,415 | -7.47% | ✓ | $694.8K |
| Sep 13, 2022 | Oct 27, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -22,500 | -8.78% | ✓ | $656.6K |
| Oct 6, 2022 | Oct 7, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 22.5 | -22,500 | -10.77% | ✓ | $884K |
| Sep 30, 2022 | Oct 4, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 15.0 | -45,000 | -18.45% | ✓ | $1.5M |
| Sep 13, 2022 | Sep 15, 2022 | Akero Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -22,500 | -9.13% | ✓ | $656.6K |